Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA
- PMID: 2000402
- PMCID: PMC51150
- DOI: 10.1073/pnas.88.5.1982
Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA
Abstract
A DNA restriction fragment with convergent SP6 and T7 promoters has undergone reaction with cis-diamminedichloroplatinum(II) (cis-DDP) and was then used as a template for RNA synthesis in vitro. The T7 and SP6 RNA polymerases generate fragments of defined sizes. Analysis of the RNA fragments shows that the polymerases are mainly blocked at the level of the d(GG) and d(AG) sites and to a lesser extent at the level of the d(GC) sites. The adducts at the d(GC) sites are more resistant to cyanide ion attack than those at the major sites and are identified as interstrand cross-links. The formation of an interstrand cross-link between the N-7 atoms of two guanine residues at the d(GC) sites was further confirmed by chemical modifications.
Similar articles
-
DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues.Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5345-9. doi: 10.1073/pnas.90.11.5345. Proc Natl Acad Sci U S A. 1993. PMID: 8506383 Free PMC article.
-
Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II).Biochemistry. 1991 Jan 8;30(1):222-30. doi: 10.1021/bi00215a032. Biochemistry. 1991. PMID: 1988023
-
RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II).Biochemistry. 1992 Feb 25;31(7):1904-8. doi: 10.1021/bi00122a002. Biochemistry. 1992. PMID: 1536834
-
Mode of DNA binding of cis-platinum(II) antitumor drugs: a base sequence-dependent mechanism is proposed.Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1445-52. Cancer Treat Rep. 1979. PMID: 387222 Review.
-
Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA.Biochim Biophys Acta. 1985;780(3):167-80. doi: 10.1016/0304-419x(85)90001-0. Biochim Biophys Acta. 1985. PMID: 3896310 Review. No abstract available.
Cited by
-
DNA bending and unwinding due to the major 1,2-GG intrastrand cross-link formed by antitumor cis-diamminedichloroplatinum(II) are flanking-base independent.Nucleic Acids Res. 2002 Jul 1;30(13):2894-8. doi: 10.1093/nar/gkf405. Nucleic Acids Res. 2002. PMID: 12087174 Free PMC article.
-
Nucleolar damage correlates with neurotoxicity induced by different platinum drugs.Br J Cancer. 2001 Oct 19;85(8):1219-25. doi: 10.1054/bjoc.2001.2024. Br J Cancer. 2001. PMID: 11710838 Free PMC article.
-
A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.Br J Cancer. 1993 Jun;67(6):1285-92. doi: 10.1038/bjc.1993.239. Br J Cancer. 1993. PMID: 8512813 Free PMC article.
-
Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.Nucleic Acids Res. 1993 Dec 25;21(25):5846-51. doi: 10.1093/nar/21.25.5846. Nucleic Acids Res. 1993. PMID: 8290343 Free PMC article.
-
DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2].Nucleic Acids Res. 1996 Jan 15;24(2):336-41. doi: 10.1093/nar/24.2.336. Nucleic Acids Res. 1996. PMID: 8628659 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous